当前位置：首页 > 文献互助 > 互助详情

24-Week Real-World Effectiveness and Safety of Lebrikizumab for Atopic Dermatitis in Japan: An Analysis Stratified by Prior Systemic Therapy复制

用户lCrXlT2ANPjQ 1小时前 7 10 待确认 帖子自动结束时间: 2026-07-07 17:20:12

1. 请及时下载文件确认是否正确, 系统将在 2026-07-09 17:51:50 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1089/derm.2025.0045复制

文献链接: https://journals.sagepub.com/doi/10.1089/derm.2025.0045复制

其他信息:

出版社: SAGE Publications
作者: Teppei Hagino; Akihiko Uchiyama; Marina Onda; Keiji Kosaka; Takeshi Araki; Sei-ichiro Motegi; Hidehisa Saeki; Eita Fujimoto; Naoko Kanda
全文下载地址: https://journals.sagepub.com/doi/pdf/10.1089/derm.2025.0045

上一篇：48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients

下一篇：Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: a post-hoc analysis of a phase III trial

互助时间线

2026-07-02 17:51:50 [上传文件]

甜蜜阳光上传了文件(pdf 1.17 MB), 求助状态变成 待确认

2026-07-02 17:20:12 [发起求助]

最新发布的求助

Neuroprotective effects of Gastrodia elata and its compounds in a Caenorhabditis elegans Alzheimer’s disease model 57分钟前
Baicalin alleviates pathological changes in Alzheimer's disease comorbid with type 2 diabetes: Targeting metabolic dysregulation and neuroinflammation 57分钟前
Integrated untargeted and targeted metabolomics to reveal the mechanisms of herbal medicine HLXLD on Alzheimer's disease 57分钟前
Dihuang Yinzi Regulates cAMP/PKA/CREB-BDNF to Improve Synaptic Plasticity in APP/PS1 Mice: A Study Based on Brain Metabolomics 57分钟前
Total Lignans From Leaves of Schisandra chinensis Improve Alzheimer's Disease Pathology Through the Nrf2/HO-1/NLRP3 Pathway 57分钟前
RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis 1小时前
Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: a post-hoc analysis of a phase III trial 1小时前
24-Week Real-World Effectiveness and Safety of Lebrikizumab for Atopic Dermatitis in Japan: An Analysis Stratified by Prior Systemic Therapy 1小时前
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients 1小时前
Resolving cellular dynamics using single-cell temporal transcriptomics 2小时前
Constructing Protein-Scaffolded Multienzyme Assembly Enhances the Coupling Efficiency of the P450 System for Efficient Daidzein Biosynthesis from (2S)-Naringenin 2小时前
Breakthrough therapy designations in China and the United States 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com